Clinical Trial Update: A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining the prevention of mild to moderate intermittent bronchial asthma using the Chinese medicine Weiyang Yuping Fang.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• Weiyang Yuping Fang

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Bronchial Asthma | Phase 2 | Status: UNKNOWN